Inovio Pharmaceuticals (NSDQ:INO) said today that it priced an offering of $65 million of 6.5% convertible senior notes due 2024.
The Plymouth Meeting, Penn.-based company also gave initial purchasers a 13-day option to buy up to an additional $20 million in notes.
Get the full story at our sister site, Drug Delivery Business News.
The post Inovio prices $65m senior notes offering appeared first on MassDevice.